Literature DB >> 7684407

Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus.

K F Helm1, M S Peters.   

Abstract

BACKGROUND: The membrane attack complex (MAC; C5b-9) localizes in the basement membrane zone (BMZ) of cutaneous lesions from patients with lupus erythematosus (LE) and has been implicated in the pathogenesis of this disease.
OBJECTIVE: Our purpose was to compare the frequency of MAC deposition with that of immunoglobulin and C3 deposition (lupus band).
METHODS: We studied 56 skin biopsy specimens from 42 patients with LE by direct immunofluorescence.
RESULTS: MAC was deposited in a granular pattern at the BMZ in 29 of 38 biopsy specimens (76%) from lesional skin; 5 of 38 specimens (13%) had focal or weak segmental deposition and 4 of 38 (11%) were negative. In contrast, IgG, IgM, IgA, and C3 were detected in 16 of 38 specimens (42%), 30 of 38 (79%), 4 of 38 (11%), and 22 of 38 (58%), respectively. None of the uninvolved skin biopsy specimens was MAC positive, although 4 of 18 (22%), 5 of 18 (28%), 1 of 18 (6%), and 2 of 18 (11%) were positive for IgG, IgM, IgA, and C3, respectively.
CONCLUSION: MAC deposition in lesional skin appears to be a relatively sensitive and specific marker for cutaneous LE and may be useful as an adjunct to the "lupus band" test.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684407     DOI: 10.1016/0190-9622(93)70093-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

2.  Direct immunofluorescence in Behçet's disease: a controlled study with 108 cases.

Authors:  Afet Akdag Kose
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

Review 3.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Julie H Lin; Jan P Dutz; Richard D Sontheimer; Victoria P Werth
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

Review 4.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09

5.  Correlation of cutaneous immunoreactants in lesional skin with the serological disorders and disease activity of systemic lupus erythematosus.

Authors:  Yi-jin Luo; Guo-zhen Tan; Min Yu; Kai-wen Li; Yue-yang Liu; Qing Guo; Fan-qin Zeng; Liangchun Wang
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.